You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daratumumab (JNJ-54767414)

Showing 26 - 50 of 632
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

Amyloidosis Trial in Worldwide (Daratumumab, Cyclophosphamide, Bortezomib)

Recruiting
  • Amyloidosis
  • Duarte, California
  • +46 more
Aug 5, 2022

Multiple Myeloma Trial in Japan (Daratumumab (16 mg/kg), Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Daratumumab (16 mg/kg)
  • +2 more
  • Hiroshima, Japan
  • +4 more
Apr 2, 2020

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Teclistamab (Tec)
  • +4 more
  • Berlin, Germany
  • +8 more
Jan 19, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Healthy Trial in Tempe (Daratumumab, Placebo, rHuPH20)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Sep 4, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Indianapolis, Rochester, Wauwatosa (Bortezomib,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Indianapolis, Indiana
  • +2 more
Sep 29, 2020

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Plasma Cell Myeloma Trial in Columbus (Daratumumab)

Completed
Has Results
  • Plasma Cell Myeloma
  • Daratumumab
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 14, 2019

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Multiple Myeloma Trial in Japan (JNJ-54767414 (Daratumumab), Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • JNJ-54767414 (Daratumumab)
  • +2 more
  • Hiroshima, Japan
  • +4 more
Mar 5, 2019

Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +145 more
Jan 17, 2023

NSCLC Trial in Worldwide (Atezolizumab, Daratumumab)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Loma Linda, California
  • +46 more
Nov 5, 2019

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tucson, Arizona
  • +191 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022

Smoldering Plasma Cell Myeloma Trial in United States (biological, drug, other)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Daratumumab
  • +4 more
  • Anchorage, Alaska
  • +595 more
Dec 7, 2022

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023